Cyclerion Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cyclerion Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q2 2024.
  • Cyclerion Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was 24.1 %.
  • Cyclerion Therapeutics, Inc. annual Return On Assets for 2023 was -42 %, a 70.3% increase from 2022.
  • Cyclerion Therapeutics, Inc. annual Return On Assets for 2022 was -141 %, a 107% decline from 2021.
  • Cyclerion Therapeutics, Inc. annual Return On Assets for 2021 was -68.2 %, a 12.9% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 24.1 +202 Apr 1, 2024 Jun 30, 2024
Q1 2024 1.19 +171 Jan 1, 2024 Mar 31, 2024
Q4 2023 -42 +99.2 +70.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -78.7 +51.6 +39.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -178 -73.3 -69.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -170 -77 -83.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -141 -73 -107% Oct 1, 2022 Dec 31, 2022
Q3 2022 -130 -70.4 -118% Jul 1, 2022 Sep 30, 2022
Q2 2022 -105 -47.2 -81.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -92.5 -38.2 -70.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -68.2 -7.79 -12.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -59.8 -2.04 -3.53% Jul 1, 2021 Sep 30, 2021
Q2 2021 -57.9 -1.84 -3.28% Apr 1, 2021 Jun 30, 2021
Q1 2021 -54.4 +0.5 +0.91% Jan 1, 2021 Mar 31, 2021
Q4 2020 -60.5 +16.3 +21.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -57.8 +52.8 +47.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -56.1 Apr 1, 2020 Jun 30, 2020
Q1 2020 -54.9 Jan 1, 2020 Mar 31, 2020
Q4 2019 -76.7 Oct 1, 2019 Dec 31, 2019
Q3 2019 -111 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.